136 related articles for article (PubMed ID: 37723924)
1. Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease.
Conger N; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA
J Mol Recognit; 2023 Dec; 36(12):e3059. PubMed ID: 37723924
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel thiosemicarbazone derivatives and investigation of their dual AChE and MAO-B inhibitor effects.
Uytun AN; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA
J Mol Recognit; 2022 Dec; 35(12):e2990. PubMed ID: 36056718
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti-Alzheimer's agents.
Shamsimeymandi R; Pourshojaei Y; Eskandari K; Mohammadi-Khanaposhtani M; Abiri A; Khodadadi A; Langarizadeh A; Sharififar F; Amirheidari B; Akbarzadeh T; Lotfian H; Foroumadi A; Asadipour A
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800352. PubMed ID: 31136018
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of bakuchiol derivatives as multi-target agents for the treatment of Alzheimer's disease.
Zhang XQ; Xiang YN; Qin T; Zou JP; Guo QW; Han ST; Zhang ZY; Liu WW; Ding G; Dong JQ; Shi DH
Fitoterapia; 2024 Apr; 174():105867. PubMed ID: 38382891
[TBL] [Abstract][Full Text] [Related]
5. Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation.
Hasan AH; Murugesan S; Amran SI; Chander S; Alanazi MM; Hadda TB; Shakya S; Pratama MRF; Das B; Biswas S; Jamalis J
Bioorg Chem; 2022 Feb; 119():105572. PubMed ID: 34971946
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
Rahim F; Ullah H; Taha M; Hussain R; Sarfraz M; Iqbal R; Iqbal N; Khan S; Ali Shah SA; Albalawi MA; Abdelaziz MA; Alatawi FS; Alasmari A; Sakran MI; Zidan N; Jafri I; Khan KM
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615218
[TBL] [Abstract][Full Text] [Related]
7. 2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors.
Basri R; Fatima S; Jalil S; Imran A; Fatima N; Syed A; Bahkali AH; Iqbal J; Shafiq Z
Arch Pharm (Weinheim); 2023 Nov; 356(11):e2300430. PubMed ID: 37718357
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular modeling studies of modulated benzyloxychalcones as potential acetylcholinesterase inhibitors.
Abdalla Ali A; Mhamad SA; Hasan AH; Ahmad I; Abdullah SA; Jamil S; Patel H; Murugesan S; Jamalis J
J Biomol Struct Dyn; 2024 Apr; 42(7):3604-3615. PubMed ID: 37293930
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, molecular docking, dynamics simulations, and
Işık A; Çevik UA; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2022 Nov; 77(11-12):447-457. PubMed ID: 35599239
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
11. N-Substituted Arylidene-3-(Methylsulfonyl)-2-Oxoimidazolidine-1-Carbohydrazide as Cholinesterase Inhibitors: Design, Synthesis, and Molecular Docking Study.
Tok F; Sağlık BN; Özkay Y; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Chem Biodivers; 2022 Aug; 19(8):e202200265. PubMed ID: 35762037
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease.
Amin KM; Abdel Rahman DE; Abdelrasheed Allam H; El-Zoheiry HH
Bioorg Chem; 2021 May; 110():104792. PubMed ID: 33799178
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
14. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
[TBL] [Abstract][Full Text] [Related]
16. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures,
Nisar M; Gondal HY; Cheema ZM; Yousaf S; Nadeem H
J Biomol Struct Dyn; 2023; 41(24):15535-15548. PubMed ID: 37021341
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
[TBL] [Abstract][Full Text] [Related]
18. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors.
Yu D; Yang C; Liu Y; Lu T; Li L; Chen G; Liu Z; Li Y
Sci Rep; 2023 Mar; 13(1):4877. PubMed ID: 36966194
[TBL] [Abstract][Full Text] [Related]
20. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]